ArticleIranian journal of basic medical sciences2018

CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.

Leyla Norouzi-Barough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.